☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Chronic Hepatitis B
Arbutus to Discontinue its P-Ia/Ib Clinical Study of AB-506 to Treat Patients with Chronic Hepatitis B
October 4, 2019
Janssen Signs Exclusive Worldwide Agreement with Arrowhead for $3.7B
October 5, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
